https://www.biospace.com/sybleu-inc-obtains-exclusive-license-for-artificial-intelligence-machine-learning-small-molecule-drug-design-engine
Sybleu Inc. Obtains Exclusive License for Artificial Intelligence/ Machine Learning Small Molecule...
Jun 27, 2023 - SYBLEU INC. (OTC PINK: SYBE), a biotechnology company focused on therapies for human and animal health, medical devices, and clinical diagnostics, is preparing...
exclusive license